Table 2.
Demographic and baseline characteristics of healthy volunteers who participated in the clinical drug-drug interaction study between nizatidine and metformin
| Characteristic | N = 12 |
|---|---|
|
| |
| Age (years) | |
| Mean (range) | 27 (23 – 33) |
|
| |
| Sex, n (%) | |
| Male | 6 (50.0) |
| Female | 6 (50.0) |
|
| |
| Ethnicity, n (%) | |
| African American | 6 (50.0) |
| Caucasian | 3 (25.0) |
| Asian American | 3 (25.0) |
|
| |
| Weight (kg) | |
| Mean (range) | 74 (49 – 101) |
|
| |
| Height (cm) | |
| Mean (range) | 176 (160 – 192) |
|
| |
| BMI (kg/m2) | |
| Mean (range) | 23.9 (18.1 – 28.6) |
|
| |
| eGFR (mL/min) | |
| Mean (range) | 114 (89 – 143) |
BMI, body mass index; eGFR, estimation of glomerular filtration rate as assessed by MDRD (Modification of Diet in Renal Disease) at screening using the African American correction factor when relevant.